Responsive afatinib treatment in high-grade salivary gland ductal carcinoma and NSCLC with uncommon EGFR mutations: Treatment outcomes
In recent years, targeted therapies have revolutionized cancer treatment, particularly for tumors with specific genetic alterations. High-grade salivary gland ductal carcinoma and non-small cell lung cancer (NSCLC) are two distinct malignancies characterized by unique challenges but share uncommon e...
Saved in:
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-06-01
|
| Series: | Oral Oncology Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2772906024003856 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|